期刊文献+

血清新蝶呤对急性冠脉综合征患者的临床诊断价值探讨(附50例分析)

Clinical value of plasma neopterin in patients with acute coronary syndromes:Analysis of 50 cases
下载PDF
导出
摘要 目的探讨新蝶呤在急性冠脉综合征患者的临床诊断中的价值。方法50例临床诊断冠心病患者,年龄53±11岁。每例患者均以冠脉造影技术从主动脉根部(AO)及冠状窦(CS)采血。采自CS与AO的血清新蝶呤以酶联免疫吸附法测定。结果UAP组及AMI组冠状窦与主动脉血清新蝶呤浓度差高于SAP组(P<0·05及P<0·01)。结论新蝶呤作为单核吞噬细胞激活的标志,对急性冠脉综合征的临床诊断有一定的应用价值。 Objective To analysis clinical value of neopterin by investigating plasma neopterin in patients with coronary heart disease. Methods Blood samples were obtained from the aortic root (AO) and coronary sinus (CS) of 50 patients, aging 53±11 years. Neopterin concentrations were measured by using an enzyme-linked immunosorbent assay method and the CSAO differences were calculated. Results Concentration of plasma neopterin in patients with UAP or AMI was higher than in patients with SAP (P〈0.05&P〈0.01). Conclusion The results indicate that neopterin is a useful marker of ACS in pa- tients with CAD, acting as an index of the activity of monocytes/macrophages.
作者 何家科
出处 《福建医药杂志》 CAS 2007年第4期6-7,共2页 Fujian Medical Journal
关键词 急性冠脉综合征 新蝶呤 动脉粥样硬化 Acute coronary syndromes Neopterin Atherosclerosis
  • 相关文献

参考文献10

  • 1Ross R.Atherosclerosis is an inflammatory disease.Am Heart J,1999,138:S419-S420.
  • 2Shah PK,Moreno P,Falke E.Pathophysiology of plaque rupture.Vasc Med Biol,1995,5:244-258.
  • 3朱志军,黄元伟,任森根,胡中荣.冠心病免疫激活的一个指标—新蝶呤[J].中国心血管杂志,2005,10(1):31-32. 被引量:9
  • 4宋尚明,刘同宝,陈良华.新喋呤与动脉粥样硬化及冠心病[J].临床心血管病杂志,2002,18(9):474-475. 被引量:9
  • 5Huber C,Batchelor JR,Fuchs D,et al.Immune response-associated production of neopterin:Release from macrophages primarily under control of interferon gamma.J Exp Med,1984,160:310-316.
  • 6Xavier GM,Fabio C,Della COLE,et al.Serum neopterin and complex stenosis morphology in patients with unstable angina.J Am coll Cardiol,2000,35:956-962.
  • 7姜霞,田凤石,熊湘明,吕锦,王金良,许静,卢凤民.血清新蝶呤对冠心病患者的临床诊断价值[J].天津医药,2005,33(5):257-259. 被引量:6
  • 8Takayuki Tanaka,Yuichi Nakamura,Akimitsu Nasuno,et al.Salicylate plasma concentrations of monocyte chemoattractant rotein 1 (MCP-1) and neopterin in the coronary circulation of patients with coronary artery disease.Circ J,2004,68:114-120.
  • 9Rifai N,Ridker PM.High-sensitivity C-reactive protein lovel and promising maker of coronary heart disease.Clin Chem,2001,47:403-411.
  • 10Samsonov M,Nassonov R,Dhzuzenova B,et al.Serum neopterin in hepatitis B.Klin Med Mosk,1992,70 (3-4):40.

二级参考文献29

  • 1[1]Ross R. Atherosclerosis is an inflammatory disease. Am Heart J,1999,138(5 PT 2):S419-420.
  • 2[2]Weissberg P L.Atherosclerosis:Current understanding of the cause of atheroma. Heart, 2000,83(2):247-252.
  • 3[3]Schumacher M, Halwachs G, Tatzber F, et al. Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol,1997,30(3):703-707.
  • 4[4]Gurfinkel E P, Scirica B M, Bozovich G, et al. Serum neopterin levels and the angiographic extent of coronary arterial narrowing in unstable angina pectoris and in non-Q-wave acute myocardial infarction. Am J Cardiol, 1999,83(4):515-518.
  • 5[5]Gupta S, Fredericks S, Schwartzman R A, et al. Serum meopterin in acute coronary syndromes. Lancet,1997,349(9060):1252-1253.
  • 6[6]Kashi J C. Increased neopterin in patients with chronic and acute coronary syndromes. J Am Coll Cardiol, 1998,31(5):1215-1216.
  • 7[7]Garcia-Moll X, Coccolo F, Cole D, et al. Serum neopterin and complex stenosis morphology in patients with unstable angina. J Am Cardiol, 2000,35(4):956-962.
  • 8[8]Garcia-Moll X, Cole D, Zouridakis E, et al. Increased serum neopterin: A marker of coronary arterial disease activity in women. Heart,2000,83(3):346-350.
  • 9Ross R. Atherosclerosis-an inflammatory disease [J].N Engl J Med, 1999, 340: 115-126.
  • 10Curtiss LK, Kubo N, Schillrt NK, et al. Participation of innate and acquired immunity in atherosclerosis[J].Immunol Res, 2000, 21: 167-176.

共引文献19

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部